EW - Edwards Lifesciences Q3 2022 Earnings Preview

• Edwards Lifesciences ( NYSE: EW ) is scheduled to announce Q3 earnings results on Thursday, October 27th, after market close.
• The consensus EPS Estimate is $0.62 and the consensus Revenue Estimate is $1.33B (+1.5% Y/Y).
• Over the last 2 years, EW has beaten EPS estimates 63% of the time and has beaten revenue estimates 75% of the time.
• Over the last 3 months, EPS estimates have seen 0 upward revisions and 17 downward. Revenue estimates have seen 0 upward revisions and 16 downward.

For further details see: